Greenwood Capital Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,583
| Closed | -$443K | – | 234 |
|
|
2022
Q3 | $443K | Buy |
+5,583
| New | +$443K | 0.08% | 187 |
|
|
2021
Q4 | – | Sell |
-4,572
| Closed | -$575K | – | 231 |
|
|
2021
Q3 | $575K | Sell |
4,572
-784
| -15% | -$98.6K | 0.09% | 175 |
|
|
2021
Q2 | $725K | Buy |
+5,356
| New | +$725K | 0.11% | 146 |
|
|
2021
Q1 | – | Sell |
-5,782
| Closed | -$814K | – | 236 |
|
|
2020
Q4 | $814K | Buy |
+5,782
| New | +$814K | 0.14% | 126 |
|
|
2020
Q2 | – | Sell |
-24,403
| Closed | -$1.89M | – | 201 |
|
|
2020
Q1 | $1.89M | Buy |
+24,403
| New | +$1.89M | 0.55% | 54 |
|
|
2018
Q3 | – | Sell |
-29,567
| Closed | -$2.81M | – | 224 |
|
|
2018
Q2 | $2.81M | Buy |
+29,567
| New | +$2.81M | 0.65% | 62 |
|
|
2018
Q1 | – | Sell |
-3,391
| Closed | -$288K | – | 230 |
|
|
2017
Q4 | $288K | Sell |
3,391
-294
| -8% | -$25K | 0.07% | 156 |
|
|
2017
Q3 | $319K | Buy |
+3,685
| New | +$319K | 0.08% | 140 |
|